Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2118)
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
24,218
Price
$33.56
Total Value
$812.84K
Shares Held After
1,146,631
% of Holdings
2.1%
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
75,782
Price
$33.00
Total Value
$2.50M
Shares Held After
1,122,413
% of Holdings
6.8%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
15,000
Price
$20.27
Total Value
$304.12K
Shares Held After
364,786
% of Holdings
3.9%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
625
Price
$99.15
Total Value
$61.97K
Shares Held After
49,249
% of Holdings
1.3%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, R&D
Shares
18,667
Price
$94.24
Total Value
$1.76M
Shares Held After
234,800
% of Holdings
7.4%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
18,650
Price
$25.93
Total Value
$483.59K
Shares Held After
22,129
% of Holdings
45.7%
Orthofix Medical Inc. (OFIX)
Vitale Lucas — CP&BOO
Shares
4,269
Price
$11.92
Total Value
$50.89K
Shares Held After
160,449
% of Holdings
2.6%
PROCEPT BioRobotics Corp (PRCT)
Nouri Alaleh — EVP, CLO, CORP. SEC.
Shares
304
Price
$28.15
Total Value
$8.56K
Shares Held After
110,717
% of Holdings
0.3%
PROCEPT BioRobotics Corp (PRCT)
Waters Kevin — EVP, CFO
Shares
706
Price
$28.15
Total Value
$19.88K
Shares Held After
151,558
% of Holdings
0.5%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Sabag Mark — See "Remarks"
Shares
62,102
Price
$30.14
Total Value
$1.87M
Shares Held After
224,940
% of Holdings
21.6%
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,731
Price
$18.91
Total Value
$32.73K
Shares Held After
56,630
% of Holdings
3.1%
Twist Bioscience Corp (TWST)
CHESS ROBERT — Director
Shares
10,000
Price
$47.00
Total Value
$470.00K
Shares Held After
21,084
% of Holdings
32.2%
MAXCYTE, INC. (MXCT)
Swirsky Douglas J — CHIEF FINANCIAL OFFICER
Shares
10,142
Price
$0.81
Total Value
$8.27K
Shares Held After
151,669
% of Holdings
6.3%
Evolus, Inc. (EOLS)
MOATAZEDI DAVID — Director
Shares
116,720
Price
$4.89
Total Value
$570.56K
Shares Held After
618,369
% of Holdings
15.9%
Evolus, Inc. (EOLS)
Avelar Rui — Chief Medical Officer and Head of Research & Development
Shares
29,996
Price
$4.89
Total Value
$146.63K
Shares Held After
430,542
% of Holdings
6.5%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
405
Price
$56.26
Total Value
$22.79K
Shares Held After
28,975
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
1,487
Price
$55.39
Total Value
$82.36K
Shares Held After
29,380
% of Holdings
4.8%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
10,043
Price
$28.10
Total Value
$282.21K
Shares Held After
62,085
% of Holdings
13.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.40
Total Value
$255.40K
Shares Held After
499,258
% of Holdings
3.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
22,290
Price
$50.73
Total Value
$1.13M
Shares Held After
17,044
% of Holdings
56.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
27,710
Price
$49.95
Total Value
$1.38M
Shares Held After
39,334
% of Holdings
41.3%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
10,172
Price
$73.21
Total Value
$744.66K
Shares Held After
82,660
% of Holdings
11.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
23,928
Price
$62.15
Total Value
$1.49M
Shares Held After
430,330
% of Holdings
5.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
12,673
Price
$62.15
Total Value
$787.63K
Shares Held After
454,258
% of Holdings
2.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
4,397
Price
$62.15
Total Value
$273.27K
Shares Held After
153,902
% of Holdings
2.8%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
7,636
Price
$62.15
Total Value
$474.58K
Shares Held After
158,299
% of Holdings
4.6%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,916
Price
$62.15
Total Value
$181.23K
Shares Held After
71,573
% of Holdings
3.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$538.41
Total Value
$587.40K
Shares Held After
43,082
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.32
Total Value
$537.32K
Shares Held After
44,173
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$536.26
Total Value
$986.71K
Shares Held After
45,173
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$535.05
Total Value
$388.98K
Shares Held After
47,013
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,076
Price
$534.14
Total Value
$574.74K
Shares Held After
47,740
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
667
Price
$533.16
Total Value
$355.62K
Shares Held After
48,816
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$532.24
Total Value
$211.30K
Shares Held After
49,483
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$531.21
Total Value
$70.65K
Shares Held After
49,880
% of Holdings
0.3%
TANDEM DIABETES CARE INC (TNDM)
Novara Mark David — EVP & CHIEF COMMERCIAL OFFICER
Shares
187
Price
$23.05
Total Value
$4.31K
Shares Held After
37,656
% of Holdings
0.5%
Esperion Therapeutics, Inc. (ESPR)
Looker Benjamin — Chief Legal Officer
Shares
5,708
Price
$2.70
Total Value
$15.43K
Shares Held After
679,348
% of Holdings
0.8%
Esperion Therapeutics, Inc. (ESPR)
Halladay Benjamin — Chief Financial Officer
Shares
6,424
Price
$2.71
Total Value
$17.38K
Shares Held After
713,602
% of Holdings
0.9%
Esperion Therapeutics, Inc. (ESPR)
Koenig Sheldon L. — Director
Shares
25,578
Price
$2.72
Total Value
$69.55K
Shares Held After
2,172,699
% of Holdings
1.2%
Hims & Hers Health, Inc. (HIMS)
Becklund Irene — PAO
Shares
5,529
Price
$24.69
Total Value
$136.51K
Shares Held After
8,752
% of Holdings
38.7%
Hims & Hers Health, Inc. (HIMS)
Chi Michael — Chief Operating Officer
Shares
97,289
Price
$24.69
Total Value
$2.40M
Shares Held After
407,282
% of Holdings
19.3%
Hims & Hers Health, Inc. (HIMS)
Boughton Soleil — Chief Legal Officer
Shares
4,812
Price
$24.69
Total Value
$118.81K
Shares Held After
308,831
% of Holdings
1.5%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
2,500
Price
$102.43
Total Value
$256.08K
Shares Held After
2,240,000
% of Holdings
0.1%
Showing 201–250 of 2118 transactions (page 5 of 43)